Concurrently, lymphocytes that infiltrate the tumor often show increased levels of immune checkpoint proteins, including lymphocyte-activation gene 3 (LAG-3), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and programmed death 1 (PD-1). The gene discussed is LAG3; the disease is neoplasm.